SQUAWK/NEWS
Menu
Live News EQUITY FLASH H impact

Karyopharm Therapeutics to request priority review

Karyopharm seeks priority review for selinexor

KPTI

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.